Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion type Assertion NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_head.
- NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion wasGeneratedBy ECO_0000203 NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_provenance.
- NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion wasDerivedFrom befree-20140225 NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_provenance.
- NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion SIO_000772 22672749 NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_provenance.
- NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion evidence source_evidence_literature NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_provenance.
- NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_assertion description "[Cetuximab-containing chemotherapy is known to be effective for KRAS wild-type metastatic colorectal cancer; however, it is not clear whether cetuximab-based preoperative chemoradiation confers an additional benefit compared with chemoradiation without cetuximab in patients with locally advanced rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP467902.RA0HUnTn7u71G5KhxQBTkXHERm3XQQnX_U0R52gYf0jpM130_provenance.